Conference News

AAAP 2020 Brief Overdose Training for Med Students Yields Lasting Benefits A program that trained medical students to prevent and handle opioid overdose had an enduring impact on students' knowledge and attitudes toward harm reduction, new research shows.
News, December 18, 2020
Should We Use Antibiotics to Treat Sore Throats? The use of antibiotics to treat a sore throat remains contentious, with guidelines from around the world providing contradictory advice.
News, December 18, 2020
AAAP 2020 Shared Medical Appointments May Bridge the Opioid Treatment Gap Although preferring one-on-one visits, individuals receiving outpatient treatment for opioid use disorder in a new study reported a high degree of satisfaction with shared medical appointments.
News, December 17, 2020
AAAP 2020 No Benefit of Cannabis on Depression in Pregnant Women With OUD Pregnant women who used cannabis to alleviate depressive symptoms while enrolled in a treatment program for opioid use disorder (OUD) experienced no benefit.
News, December 17, 2020
AIBD 2020 Alternative Therapy Plea May Be a Cry for Help Physicians should find out why patients want to try something different. The approved medication may not be working or they may feel lack of control.
News, December 16, 2020
SABCS 2020 A Disappointment in Triple-Negative Breast Cancer The oral AKT inhibitor ipatasertib does not seem to offer any clinical benefit when added to paclitaxel for women with gene-altered advanced triple- negative breast cancer, indicate phase 3 trial data.
News, December 16, 2020
AIBD 2020 Virtual Reality Augmenting Therapy in Gastroenterology and Beyond More than 200 hospitals are using VR. Patients can float in outer space, swim with dolphins, or learn breathing techniques to manage pain or procedural anxiety. An IBS therapeutic is under development.
News, December 15, 2020
AAAP 2020 ADHD Meds May Boost Treatment Retention in Comorbid Addiction Judicious use of stimulants may help patients with ADHD and comorbid substance use disorder stay in addiction treatment programs, new research shows.
News, December 15, 2020
SABCS 2020 Pembro Benefits in mTNBC Regardless of Chemo Type The type of chemotherapy regimen accompanying pembrolizumab does not appear to affect outcomes in women with untreated advanced triple negative breast cancer, suggests an analysis of key trial data.
News, December 15, 2020
AES 2020 Psychogenic Seizures Tied to Sexual Assault, Stroke Individuals who have experienced sexual trauma have more than a tenfold increased risk of developing psychogenic nonepileptic seizures and are also more likely to suffer a stroke, new research shows.
News, December 15, 2020
SABCS 2020 Pregnancy After Breast Cancer Doesn't Increase Recurrence Risk Among women who became pregnant, breast cancer survivors did not have higher odds of miscarriage or complications like preeclampsia, and their babies were not more likely to have congenital abnormalities.
News, December 14, 2020
SABCS 2020 Adding Atezolizumab to Chemo Doesn't Worsen QOL in Early TNBC Data from the Impassion031 trial showed that, after a brief decline in health-related QoL in the atezolizumab and control arms, the burden of treatment eased and then remained similar through follow-up.
News, December 14, 2020
AAAP 2020 COVID-19 Drives Innovation in Addiction Treatment With face-to-face substance use disorder recovery meetings becoming unsafe during the COVID pandemic, clinicians and patients are finding telehealth and virtual recovery meetings to be acceptable alternatives.
News, December 14, 2020
ASH 2020 Mycophenolate Shows Promise in Immune Thrombocytopenia For patients with immune thrombocytopenia, adding mycophenolate to the standard of care (steroids) resulted in half as many treatment failures as steroids alone.
News, December 14, 2020
SABCS 2020 First-in-Class ADC Has Benefit Across mTNBC Subgroups For women with pretreated metastatic triple-negative breast cancer (mTNBC), sacituzumab govitecan improved outcomes regardless of target protein expression and BRCA1/2 status, a post-trial analysis shows.
News, December 14, 2020
AES 2020 Encouraging Results for New Epilepsy Drug The new antiepileptic drug cenobamate significantly reduces seizure frequency and improves seizure freedom rates in adults with epilepsy. It also reduces the need for other antiseizure medications.
News, December 14, 2020
AIBD 2020 GI Physicians Urge COVID-19 Vaccines for All IBD Patients The frontrunner vaccine candidates do not have any replicating virus and are safe for immunocompromised people, experts say.
News, December 11, 2020
SABCS 2020 RxPONDER: Even More Women May Forgo Chemo for Breast Cancer The first results from RxPONDER provide insight – and controversy – regarding the need for chemotherapy by women with node-positive, low-risk HR+, HER2- breast cancer.
News, December 11, 2020
AIBD 2020 Partnering With Dietitians Can Bridge Gaps in IBD Care The pandemic has eased access to dietitians as many are working virtually. Websites can help search by ZIP code for those who specialize in nutrition for gastroenterologic disorders.
News, December 11, 2020
ASH 2020 First Data for CAR T-cell Therapy in Follicular Lymphoma The ZUMA-5 results show impressive responses for patients with refractory/relapsed indolent non-Hodgkin lymphoma, including follicular lymphoma and marginal zone lymphoma.
News, December 11, 2020

Conference News

About

Membership

Apps

WebMD Network

Editions

Conference News

Find Us On

About

Membership

Apps

WebMD Network

Editions